Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors-Reference-Cited by-同舟云学术

Discovery of Novel Spiroindoline Derivatives as Selective Tankyrase Inhibitors

Published:2019-03-18 Issue:7 Volume:62 Page:3407-3427
ISSN:0022-2623
Container-title:Journal of Medicinal Chemistry
language:en
Short-container-title:J. Med. Chem.

Author:

Shirai Fumiyuki^ORCID,Tsumura Takeshi,Yashiroda Yoko,Yuki Hitomi^ORCID,Niwa Hideaki,Sato Shin,Chikada Tsubasa,Koda Yasuko,Washizuka Kenichi,Yoshimoto Nobuko,Abe Masako,Onuki Tetsuo,Mazaki Yui,Hirama Chizuko,Fukami Takehiro¹,Watanabe Hirofumi,Honma Teruki^ORCID,Umehara Takashi,Shirouzu Mikako,Okue Masayuki,Kano Yuko,Watanabe Takashi,Kitamura Kouichi,Shitara Eiki,Muramatsu Yukiko²,Yoshida Haruka²,Mizutani Anna²,Seimiya Hiroyuki²,Yoshida Minoru³,Koyama Hiroo

Affiliation:

1. RIKEN Program for Drug Discovery and Medical Technology Platforms, 2-1 Hirosawa, Wako, Saitama 351-0198, Japan

2. Division of Molecular Biotherapy, Cancer Chemotherapy Center, Japanese Foundation for Cancer Research, 3-8-31 Ariake, Koto-ku, Tokyo 135-8850, Japan

3. Department of Biotechnology, The University of Tokyo, 1-1-1 Yayoi, Bunkyo-ku, Tokyo 113-8657, Japan

Funder

Japan Agency for Medical Research and Development

Publisher

American Chemical Society (ACS)

Subject

Drug Discovery,Molecular Medicine

Link

https://pubs.acs.org/doi/pdf/10.1021/acs.jmedchem.8b01888

Reference59 articles.

1. Wnt control of stem cells and differentiation in the intestinal epithelium

2. Wnt Drug Discovery: Weaving Through the Screens, Patents and Clinical Trials